Drug Discovery and Development in Cancer Research
Drug discovery is a process where the cure for the disease is found. This is a multistep process which involves a great amount of investment in terms of time and finance. Cancer is believed not be cured any drugs. However, there are many instances where people have come out of this disease successfully, thanks to the researchers who have developed some efficient molecules which can suppress and kill the tumor cells.
As a first step, the cause of the disease is identified. Here it might be a molecule or an Organism. Once the cause is identified, a hypothesis for the target molecules are drawn and certain molecule groups are chosen to encounter the target molecule/Organism. In the modern method, these molecules are chosen by algorithms and often selected from the databases based upon their structures and composition. Later these are subjected to the target molecule in silico models. Many of the molecules lose the race here and few make it to the next level of testing where the selected models are subjected to animal models. Once these molecules are proven to be safe and efficient in the animal models, they are approved to test on the human. After rigor testing and monitoring, a suitable molecule with all ideal characteristics is approved by the governing body and released into the market.
Related Conference of Drug Discovery and Development in Cancer Research
20th International Conference on Allergic Diseases and Clinical Immunology
6th International conference on Vaccines, Vaccination and Immunization
6th World Congress on Neuroimmunology and Neuroinfectious Diseases
Drug Discovery and Development in Cancer Research Conference Speakers
Recommended Sessions
- Cancer Vaccines
- Immune Checkpoint inhibitors
- Pediatric Oncology Diagnosis
- Tumor markers and drug targeting
- Antibody Therapy of Cancer
- Brain Tumors
- Cancer Biomarkers
- Cancer Clinical Trials
- Cancer Immunology & Immunotherapy
- Cancer Micro and Immuno environment
- Cancer Research and Prevention
- Combining Cancer Immunotherapies
- COVID 19 effect on Cancer Patients
- Drug Discovery and Development in Cancer Research
- Engineered T-Cell Therapy
- Immuno-Oncology studies
- Immunotherapy Monitoring
- Multiple Myeloma
- Novel Approaches in Cancer & Tumor
- Oncology Nursing and Care
- Organ-Defined Cancers
- Pediatric Cancer Surgery
- Pediatric Oncology
- Pediatrics Drug Toxicity
- Psychology in Children with Cancer
- Radiology and Imaging in Cancer
- Radiology in Pediatric Oncology
- Tumor biology and Carcinogenesis
- Tumor Immunogenicity
- Tumor Immunology and Immunotherapy
- Tumor immunotherapy research
- Tumors
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Netherlands)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Netherlands)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Netherlands)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Netherlands)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Netherlands)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)